Sublingual Immunotherapy: Insights into Clinical Benefits and Safety Profile

IAL – Allergologico. 22 Ottobre 2014. Accessed November 1, 2025. https://www.allergologico.it/news/scit-o-slit-pro-e-contro.html#:~:text=Sicurezza%20della%20SCIT%20nei%20confronti,non%20indifferente%20rispetto%20alla%20SCIT

HAL Allergy B.V. 2025. Accessed November 1, 2025. https://www.hal-allergy.com/it/immunoterapia-sublinguale/#:~:text=Il%20prodotto%20sublinguale%20(SLIT)%20assicura,alcune%20gocce%20sotto%20alla%20lingua

Garrido-Fernández S Fernández DG López GS , et al Satisfaction, Qol and adherence of patients allergic to dust mites and/or pollens undergoing sublingual immunotherapy. Immunotherapy. 2024 ;16(10):693-704. doi:10.1080/1750743x.2024.2347828

Nolte H Maloney J. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases. Allergol Int. 2018;67(3):301-308. doi:10.1016/j.alit.2018.03.008

Malaya E Piątkowska A Panek M Kuna P Kupczyk M Kardas G. Medication adherence in allergic diseases and asthma: a literature review. Front Pharmacol. 2024;15:1488665. doi:10.3389/fphar.2024.1488665

Fujita H Soyka M Akdis M Akdis C. Mechanisms of allergenspecific immunotherapy. Clin Transl Allergy. 2012;2:1-13.

Jay DC Nadeau KC. Immune mechanisms of sublingual immunotherapy. Curr Allergy Asthma Rep. 2014;14(11):473. doi:10.1007/s11882-014-0473-1

Passalacqua G Nowak-Węgrzyn A Canonica GW. Local side effects of sublingual and oral immunotherapy. J Allergy Clin Immunol Pract. 2017;5(1):13-21. doi:10.1016/j.jaip.2016.06.020

Compalati E Incorvaia C Urbano S Strada P Frati F. The safety of carbamylated monomeric allergoids for sublingual immunotherapy. Data from a pharmacovigilance study. Immunotherapy. 2020;12(3):195-202.

Canonica GW Passalacqua G. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy. 2006;61(Suppl. 81):20-23. doi:10.1111/j.1398-9995.2006.01161.x

The American Academy of Allergy. Asthma & Immunology (AAAAI), SLIT Treatment for Allergic Rhinitis Nothing to Sneeze About. October 1, 2024. Accessed November 2, 2025. https://www.aaaai.org/tools-for-the-public/conditions-library/allergies/slit-treatment-for-allergic-rhinitis-nothing-to-sn#:~:text=SLIT%20tablets%20are%20similar%20to%20allergy%20shots,*%20**Odactra%20(ALK%20Inc.)**%20Contains%20dust%20mites

FDA. Adverse Event Reporting System (FAERS) Public Dashboard. July 12, 2023. Accessed October 31, 2025. https://www.fda.gov/drugs/fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard

Moral A Moreno V Girón F , et al Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy. J Asthma Allergy. 2016;9:129-133. doi:10.2147/JAA.S107830

Mauro G Zinzi A Vitiello F , et al Adverse drug reactions and gender differences: what changes in drug safety? Ital J Gender-Specific Med. 2019;5(3):114-122. doi 10.1723/3245.32145

Lavertu A Vora B Giacomini KM Altman R Rensi S. A new era in pharmacovigilance: toward real-world data and digital monitoring. Clin Pharmacol Ther. 2021;109(5):1197-1202. doi:10.1002/cpt.2172